Daniel Schnurman is a Managing Director in Cowen’s Consumer Investment Banking Group. Mr. Schnurman’s focus is on advising medical cannabis clients as well as those interested in investing in, or expanding into, the global medical cannabis industry. He has over 20 years of banking experience, most recently at PricewaterhouseCoopers where he was the Head of Healthcare Corporate Finance, focused on originating and executing strategic transactions in the Life Sciences sector. Prior to that, he was a Managing Director on the Health Care Investment Banking team at UBS and led coverage of UBS’s Specialty and Generics Pharmaceuticals investment banking practice in the Americas.
Mr. Schnurman holds a Bachelor of Arts (Pre-Med) from Rice University, a J.D. from Washington University School of Law and an MBA from the Wharton School.